6 assets in Obsessive-Compulsive Disorder

Therapeutic assets addressing Obsessive-Compulsive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Sertraline Obsessive-Compulsive Disorder	Yang I. Pachankis, PhD	P4	BB (64)
Rituximab Obsessive-Compulsive Disorder	Uppsala University Hospital	P2	CCC (53)
Teonanacatl Obsessive-Compulsive Disorder	Yale University	P1	CC (43)